Journal of Immunology, ISSN 0022-1767, 10/2014, Volume 193, Issue 7, pp. 3600 - 3612
Tuberculosis, caused by the intracellular bacterium Mycobacterium tuberculosis, currently causes similar to 1.4 million deaths per year, and it therefore...
LISTERIA-MONOCYTOGENES | INTERFERON-GAMMA | DENDRITIC CELLS | IL-1-BETA PRODUCTION | NITRIC-OXIDE SYNTHASE | IMMUNE-RESPONSES | MURINE MACROPHAGES | PERITONEAL-MACROPHAGES | IMMUNOLOGY | HUMAN MONOCYTES | VIRAL-INFECTION | Macrophages - pathology | Interleukin-12 - genetics | Macrophage Activation - immunology | Tumor Necrosis Factor-alpha - genetics | Mycobacterium tuberculosis - immunology | Interleukin-1beta - immunology | Interferon Type I - immunology | Mice, Knockout | Tuberculosis - immunology | Interleukins - genetics | Animals | Tuberculosis - genetics | Interferon-gamma - immunology | Interleukin-10 - genetics | Interleukins - immunology | Interleukin-12 - immunology | Tumor Necrosis Factor-alpha - immunology | Interferon Type I - genetics | Mice | Interferon-gamma - genetics | Interleukin-10 - immunology | Macrophages - immunology | Macrophages - microbiology | Tuberculosis - pathology | Infectious Disease and Host Response
LISTERIA-MONOCYTOGENES | INTERFERON-GAMMA | DENDRITIC CELLS | IL-1-BETA PRODUCTION | NITRIC-OXIDE SYNTHASE | IMMUNE-RESPONSES | MURINE MACROPHAGES | PERITONEAL-MACROPHAGES | IMMUNOLOGY | HUMAN MONOCYTES | VIRAL-INFECTION | Macrophages - pathology | Interleukin-12 - genetics | Macrophage Activation - immunology | Tumor Necrosis Factor-alpha - genetics | Mycobacterium tuberculosis - immunology | Interleukin-1beta - immunology | Interferon Type I - immunology | Mice, Knockout | Tuberculosis - immunology | Interleukins - genetics | Animals | Tuberculosis - genetics | Interferon-gamma - immunology | Interleukin-10 - genetics | Interleukins - immunology | Interleukin-12 - immunology | Tumor Necrosis Factor-alpha - immunology | Interferon Type I - genetics | Mice | Interferon-gamma - genetics | Interleukin-10 - immunology | Macrophages - immunology | Macrophages - microbiology | Tuberculosis - pathology | Infectious Disease and Host Response
Journal Article
Journal of Immunology, ISSN 0022-1767, 08/2014, Volume 193, Issue 4, pp. 1622 - 1635
Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation,...
KINASE 3 LIGAND | IMMUNE-RESPONSE | STEM-CELLS | HEPATITIS-C VIRUS | INTERFERON-LAMBDA | GENERATION | ANTIGEN CROSS-PRESENTATION | IMMUNOLOGY | EXPRESSION | LANGERHANS CELLS | CUTTING EDGE | Imidazoles - immunology | Cell Line | Green Fluorescent Proteins | Toll-Like Receptor 3 | Adjuvants, Immunologic - pharmacology | Toll-Like Receptor 4 | Dendritic Cells - immunology | Humans | Gene Expression Profiling | Monocytes - immunology | Antigen Presentation - immunology | Lipopolysaccharides - immunology | Blood Cells - immunology | Receptors, G-Protein-Coupled - immunology | Cell Differentiation - immunology | Phenotype | Antigens, CD34 - immunology | Cross-Priming - immunology | Killer Cells, Natural - immunology | T-Lymphocytes - immunology | Poly I-C - immunology | Cell Culture Techniques | Clinical and Human Immunology
KINASE 3 LIGAND | IMMUNE-RESPONSE | STEM-CELLS | HEPATITIS-C VIRUS | INTERFERON-LAMBDA | GENERATION | ANTIGEN CROSS-PRESENTATION | IMMUNOLOGY | EXPRESSION | LANGERHANS CELLS | CUTTING EDGE | Imidazoles - immunology | Cell Line | Green Fluorescent Proteins | Toll-Like Receptor 3 | Adjuvants, Immunologic - pharmacology | Toll-Like Receptor 4 | Dendritic Cells - immunology | Humans | Gene Expression Profiling | Monocytes - immunology | Antigen Presentation - immunology | Lipopolysaccharides - immunology | Blood Cells - immunology | Receptors, G-Protein-Coupled - immunology | Cell Differentiation - immunology | Phenotype | Antigens, CD34 - immunology | Cross-Priming - immunology | Killer Cells, Natural - immunology | T-Lymphocytes - immunology | Poly I-C - immunology | Cell Culture Techniques | Clinical and Human Immunology
Journal Article
Journal of Immunology, ISSN 0022-1767, 11/2014, Volume 193, Issue 9, pp. 4537 - 4547
IFN-gamma-activated macrophages play an essential role in controlling intracellular pathogens; however, macrophages also serve as the cellular home for the...
PHAGOCYTOSIS | ACTIVATION | INTERFERON-GAMMA | IMMUNE-RESPONSES | KINASE | SUSCEPTIBILITY | INFECTION | IMMUNOLOGY | DEPENDENT GENE-TRANSCRIPTION | COMPLEMENT RECEPTORS | INNATE IMMUNITY | Cell Line | Reproducibility of Results | Humans | RNA, Messenger - genetics | Mycobacterium tuberculosis - immunology | Gene Expression Profiling | Receptors, IgG - metabolism | HLA-DR Antigens - genetics | Gene Expression Regulation - drug effects | Tuberculosis - immunology | p300-CBP Transcription Factors - metabolism | Macrophages - metabolism | Receptors, IgG - genetics | RNA Interference | Tuberculosis - genetics | p300-CBP Transcription Factors - genetics | Macrophages - drug effects | HLA-DR Antigens - immunology | MicroRNAs - genetics | 3' Untranslated Regions | Binding Sites | Interferon-gamma - pharmacology | Macrophages - immunology
PHAGOCYTOSIS | ACTIVATION | INTERFERON-GAMMA | IMMUNE-RESPONSES | KINASE | SUSCEPTIBILITY | INFECTION | IMMUNOLOGY | DEPENDENT GENE-TRANSCRIPTION | COMPLEMENT RECEPTORS | INNATE IMMUNITY | Cell Line | Reproducibility of Results | Humans | RNA, Messenger - genetics | Mycobacterium tuberculosis - immunology | Gene Expression Profiling | Receptors, IgG - metabolism | HLA-DR Antigens - genetics | Gene Expression Regulation - drug effects | Tuberculosis - immunology | p300-CBP Transcription Factors - metabolism | Macrophages - metabolism | Receptors, IgG - genetics | RNA Interference | Tuberculosis - genetics | p300-CBP Transcription Factors - genetics | Macrophages - drug effects | HLA-DR Antigens - immunology | MicroRNAs - genetics | 3' Untranslated Regions | Binding Sites | Interferon-gamma - pharmacology | Macrophages - immunology
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2013, Volume 188, Issue 10, pp. 1193 - 1201
Rationale: The role of airway microbiome in corticosteroid response in asthma is unknown. Objectives: To examine airway microbiome composition in patients with...
Corticosteroids | Asthma | Microbiome | COMMENSAL BACTERIA | FIBEROPTIC BRONCHOSCOPY | MACROPHAGES | STEROID-RESISTANT ASTHMA | asthma | LIPOPOLYSACCHARIDES | microbiome | corticosteroids | RESPIRATORY SYSTEM | PROTEIN-KINASE PHOSPHATASE-1 | LIPID-A | DISEASE | RECEPTOR-BETA | GLUCOCORTICOID-INSENSITIVE ASTHMA | CRITICAL CARE MEDICINE | Biomarkers - metabolism | Asthma - microbiology | Drug Administration Schedule | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | RNA, Ribosomal, 16S - analysis | Male | Treatment Outcome | Genetic Markers | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Sequence Analysis, DNA | Case-Control Studies | Bronchoalveolar Lavage Fluid - microbiology | Microbiota | Drug Resistance - physiology | Adult | DNA, Bacterial - analysis | Female | Macrophages, Alveolar - metabolism | Real-Time Polymerase Chain Reaction | Prednisone - therapeutic use
Corticosteroids | Asthma | Microbiome | COMMENSAL BACTERIA | FIBEROPTIC BRONCHOSCOPY | MACROPHAGES | STEROID-RESISTANT ASTHMA | asthma | LIPOPOLYSACCHARIDES | microbiome | corticosteroids | RESPIRATORY SYSTEM | PROTEIN-KINASE PHOSPHATASE-1 | LIPID-A | DISEASE | RECEPTOR-BETA | GLUCOCORTICOID-INSENSITIVE ASTHMA | CRITICAL CARE MEDICINE | Biomarkers - metabolism | Asthma - microbiology | Drug Administration Schedule | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | RNA, Ribosomal, 16S - analysis | Male | Treatment Outcome | Genetic Markers | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Sequence Analysis, DNA | Case-Control Studies | Bronchoalveolar Lavage Fluid - microbiology | Microbiota | Drug Resistance - physiology | Adult | DNA, Bacterial - analysis | Female | Macrophages, Alveolar - metabolism | Real-Time Polymerase Chain Reaction | Prednisone - therapeutic use
Journal Article
Journal of Leukocyte Biology, ISSN 0741-5400, 11/2015, Volume 98, Issue 5, pp. 703 - 712
Enhancing TCR signal strength can attenuate TGFβ‐mediated transcriptional changes and functions in CD8+ T cells, independent of changes to canonical TGFβ...
diacylglycerol kinase ζ | Smad2 | Diacylglycerol | Diacylglycerol kinase ζ | ACTIVATION | IMMUNE CELLS | METASTASIS | TRANSDUCTION | PROLIFERATION | DIACYLGLYCEROL KINASES | IMMUNOLOGY | CANCER | CELL BIOLOGY | GROWTH-FACTOR-BETA | INHIBITION | PATHWAY | diacylglycerol kinase zeta | HEMATOLOGY | Transforming Growth Factor beta - immunology | CD8-Positive T-Lymphocytes - cytology | Signal Transduction - genetics | Diacylglycerol Kinase - genetics | Mice, Knockout | Diacylglycerol Kinase - immunology | Signal Transduction - immunology | Smad2 Protein - immunology | Animals | Transforming Growth Factor beta - genetics | Smad2 Protein - genetics | Receptors, Antigen, T-Cell - immunology | Mice | Receptors, Antigen, T-Cell - genetics | CD8-Positive T-Lymphocytes - immunology | Spotlight on Leading Edge Research
diacylglycerol kinase ζ | Smad2 | Diacylglycerol | Diacylglycerol kinase ζ | ACTIVATION | IMMUNE CELLS | METASTASIS | TRANSDUCTION | PROLIFERATION | DIACYLGLYCEROL KINASES | IMMUNOLOGY | CANCER | CELL BIOLOGY | GROWTH-FACTOR-BETA | INHIBITION | PATHWAY | diacylglycerol kinase zeta | HEMATOLOGY | Transforming Growth Factor beta - immunology | CD8-Positive T-Lymphocytes - cytology | Signal Transduction - genetics | Diacylglycerol Kinase - genetics | Mice, Knockout | Diacylglycerol Kinase - immunology | Signal Transduction - immunology | Smad2 Protein - immunology | Animals | Transforming Growth Factor beta - genetics | Smad2 Protein - genetics | Receptors, Antigen, T-Cell - immunology | Mice | Receptors, Antigen, T-Cell - genetics | CD8-Positive T-Lymphocytes - immunology | Spotlight on Leading Edge Research
Journal Article
Journal of Immunology, ISSN 0022-1767, 05/2015, Volume 194, Issue 9, pp. 4144 - 4153
The immune and the skeletal system are tightly interconnected, and B lymphocytes are uniquely endowed with osteo-interactive properties. In this context,...
RHEUMATOID-ARTHRITIS | REGULATORY FUNCTION | BONE LOSS | AUTOIMMUNITY | IMMUNE-RESPONSES | MARGINAL ZONE | RECEPTOR ACTIVATOR | GERMINAL CENTER | IMMUNOLOGY | T-CELLS | PLASMA-CELLS | RANK Ligand - immunology | Animals | B-Lymphocytes - immunology | RANK Ligand - deficiency | Mice | Interleukin-10 - immunology | Mice, Knockout
RHEUMATOID-ARTHRITIS | REGULATORY FUNCTION | BONE LOSS | AUTOIMMUNITY | IMMUNE-RESPONSES | MARGINAL ZONE | RECEPTOR ACTIVATOR | GERMINAL CENTER | IMMUNOLOGY | T-CELLS | PLASMA-CELLS | RANK Ligand - immunology | Animals | B-Lymphocytes - immunology | RANK Ligand - deficiency | Mice | Interleukin-10 - immunology | Mice, Knockout
Journal Article
Scientific Reports, ISSN 2045-2322, 2017, Volume 7, Issue 1, pp. 807 - 12
Modulation of the immune system can produce anti-tumor responses in various cancer types, including melanoma. Recently, immune checkpoint inhibitors (ICI), in...
RESPONSES | TO-MESENCHYMAL TRANSITION | MELANOMA | THERAPY | MULTIDISCIPLINARY SCIENCES | PHENOTYPE | PROGNOSTIC-SIGNIFICANCE | ANTI-PD-1 | BLOCKADE | CANCER | EXPRESSION | Immune response | Mesenchyme | PD-1 protein | Melanoma | Lymphocytes T | Metastasis | Patients | E-cadherin | Metastases | Disease resistance | CTLA-4 protein | Immune checkpoint | Lysine | Monoclonal antibodies | Epigenetics | Methylation | Histone H3 | Tumors | Cancer
RESPONSES | TO-MESENCHYMAL TRANSITION | MELANOMA | THERAPY | MULTIDISCIPLINARY SCIENCES | PHENOTYPE | PROGNOSTIC-SIGNIFICANCE | ANTI-PD-1 | BLOCKADE | CANCER | EXPRESSION | Immune response | Mesenchyme | PD-1 protein | Melanoma | Lymphocytes T | Metastasis | Patients | E-cadherin | Metastases | Disease resistance | CTLA-4 protein | Immune checkpoint | Lysine | Monoclonal antibodies | Epigenetics | Methylation | Histone H3 | Tumors | Cancer
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 08/2008, Volume 178, Issue 4, pp. 325 - 331
Rationale: Airway responsiveness is a prognostic marker for asthma symptoms in later life. Objectives: To evaluate characteristics responsible for persistence...
Bronchoconstriction | FEV | Methacholine | YOUNG-ADULTS | MANAGEMENT PROGRAM | RISK-FACTORS | BRONCHIAL RESPONSIVENESS | SERUM IGE | LUNG-FUNCTION | PULMONARY-FUNCTION | bronchoconstriction | PC20 | RESPIRATORY SYSTEM | INHALED HISTAMINE | FEV1 | RESPIRATORY SYMPTOMS | methacholine | VITAL CAPACITY | CRITICAL CARE MEDICINE | Prognosis | Prospective Studies | Age Factors | Bronchodilator Agents - administration & dosage | Follow-Up Studies | Forced Expiratory Volume - drug effects | Humans | Bronchial Provocation Tests | Child, Preschool | Male | Puberty - physiology | Vital Capacity - drug effects | Bronchial Hyperreactivity - physiopathology | Female | Child | Methacholine Chloride | Asthma - epidemiology | Bronchoconstriction - physiology | Asthma - physiopathology | Double-Blind Method | Forced Expiratory Volume - physiology | Nedocromil - administration & dosage | Disease Progression | Sex Ratio | Vital Capacity - physiology | Adolescent | Least-Squares Analysis | Bronchial Hyperreactivity - epidemiology | Anti-Asthmatic Agents - administration & dosage | Budesonide - administration & dosage | Cohort Studies | A. Asthma and Allergy
Bronchoconstriction | FEV | Methacholine | YOUNG-ADULTS | MANAGEMENT PROGRAM | RISK-FACTORS | BRONCHIAL RESPONSIVENESS | SERUM IGE | LUNG-FUNCTION | PULMONARY-FUNCTION | bronchoconstriction | PC20 | RESPIRATORY SYSTEM | INHALED HISTAMINE | FEV1 | RESPIRATORY SYMPTOMS | methacholine | VITAL CAPACITY | CRITICAL CARE MEDICINE | Prognosis | Prospective Studies | Age Factors | Bronchodilator Agents - administration & dosage | Follow-Up Studies | Forced Expiratory Volume - drug effects | Humans | Bronchial Provocation Tests | Child, Preschool | Male | Puberty - physiology | Vital Capacity - drug effects | Bronchial Hyperreactivity - physiopathology | Female | Child | Methacholine Chloride | Asthma - epidemiology | Bronchoconstriction - physiology | Asthma - physiopathology | Double-Blind Method | Forced Expiratory Volume - physiology | Nedocromil - administration & dosage | Disease Progression | Sex Ratio | Vital Capacity - physiology | Adolescent | Least-Squares Analysis | Bronchial Hyperreactivity - epidemiology | Anti-Asthmatic Agents - administration & dosage | Budesonide - administration & dosage | Cohort Studies | A. Asthma and Allergy
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9867, pp. 690 - 697
NCDs consist of a vast group of conditions, but in terms of premature mortality, emphasis has been on cardiovascular disease, cancer, diabetes, and chronic...
Internal Medicine | GLOBAL BURDEN | MEDICINE, GENERAL & INTERNAL | INTERVENTIONS | PRIMARY-CARE | SCALE-UP | FUND-SUPPORTED PROGRAMS | HIV | LOW-INCOME | CERVICAL-CANCER | CASE-MANAGEMENT | MULTIMORBIDITY | HIV Infections - prevention & control | Primary Prevention | Universal Coverage | Delivery of Health Care - organization & administration | Humans | Chronic Disease - economics | Health Priorities | Health Services Needs and Demand | Health Services Accessibility | Pharmaceutical Preparations - supply & distribution | Tuberculosis - prevention & control | Chronic Disease - therapy | Health Planning | Low income groups | Reproductive health | Cardiovascular disease | Information management | Patients | Developing countries--LDCs | Disease prevention | Gross Domestic Product--GDP | Hospitals | Tuberculosis | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Respiratory diseases | Society | Diabetes | Human resources | Community | Cancer | Chronic illnesses
Internal Medicine | GLOBAL BURDEN | MEDICINE, GENERAL & INTERNAL | INTERVENTIONS | PRIMARY-CARE | SCALE-UP | FUND-SUPPORTED PROGRAMS | HIV | LOW-INCOME | CERVICAL-CANCER | CASE-MANAGEMENT | MULTIMORBIDITY | HIV Infections - prevention & control | Primary Prevention | Universal Coverage | Delivery of Health Care - organization & administration | Humans | Chronic Disease - economics | Health Priorities | Health Services Needs and Demand | Health Services Accessibility | Pharmaceutical Preparations - supply & distribution | Tuberculosis - prevention & control | Chronic Disease - therapy | Health Planning | Low income groups | Reproductive health | Cardiovascular disease | Information management | Patients | Developing countries--LDCs | Disease prevention | Gross Domestic Product--GDP | Hospitals | Tuberculosis | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Respiratory diseases | Society | Diabetes | Human resources | Community | Cancer | Chronic illnesses
Journal Article
Cancer Gene Therapy, ISSN 0929-1903, 03/2017, Volume 24, Issue 3, pp. 134 - 140
Recent clinical successes with immunotherapy have resulted in expanding indications for cancer therapy. To enhance antitumor immune responses, and to better...
MEDICINE, RESEARCH & EXPERIMENTAL | MUTATIONAL PROCESSES | CTLA-4 BLOCKADE | PD-1 BLOCKADE | PANCREATIC-CANCER | PHASE-III | CELL LUNG-CANCER | METASTATIC MELANOMA | THERAPY | ONCOLOGY | IMMUNE CHECKPOINT BLOCKADE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | IPILIMUMAB | Recurrence | Immunotherapy - methods | Prognosis | Antigens, Neoplasm - immunology | Humans | Gene Expression Regulation, Neoplastic | Transcriptome | Treatment Outcome | Combined Modality Therapy | Gene Expression Profiling | Genetic Markers | Molecular Targeted Therapy | Biomarkers, Tumor | Drug Resistance, Neoplasm - genetics | Neoplasms - therapy | Animals | Neoplasms - genetics | Neoplasms - immunology | DNA Damage | Mutation | Genomics - methods | Neoplasms - pathology | Immune response | Immunotherapy | Patient outcomes | Genetic aspects | Gene expression | Health aspects | Methods
MEDICINE, RESEARCH & EXPERIMENTAL | MUTATIONAL PROCESSES | CTLA-4 BLOCKADE | PD-1 BLOCKADE | PANCREATIC-CANCER | PHASE-III | CELL LUNG-CANCER | METASTATIC MELANOMA | THERAPY | ONCOLOGY | IMMUNE CHECKPOINT BLOCKADE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | IPILIMUMAB | Recurrence | Immunotherapy - methods | Prognosis | Antigens, Neoplasm - immunology | Humans | Gene Expression Regulation, Neoplastic | Transcriptome | Treatment Outcome | Combined Modality Therapy | Gene Expression Profiling | Genetic Markers | Molecular Targeted Therapy | Biomarkers, Tumor | Drug Resistance, Neoplasm - genetics | Neoplasms - therapy | Animals | Neoplasms - genetics | Neoplasms - immunology | DNA Damage | Mutation | Genomics - methods | Neoplasms - pathology | Immune response | Immunotherapy | Patient outcomes | Genetic aspects | Gene expression | Health aspects | Methods
Journal Article
The Plant Journal, ISSN 0960-7412, 11/2016, Volume 88, Issue 3, pp. 361 - 374
Summary DNA methylation is antagonistically controlled by DNA methyltransferases and DNA demethylases. The level of DNA methylation controls plant gene...
Arabidopsis thaliana | systemic acquired resistance | defence priming | Hyaloperonospora arabidopsidis | E‐MTAB‐3963 | transgenerational acquired resistance | DNA methylation | basal resistance | E-MTAB-3963 | ACID | RNA-POLYMERASE V | TRANSPOSABLE ELEMENTS | HISTONE ACETYLTRANSFERASE | PLANT SCIENCES | GETTING READY | INDUCED RESISTANCE | CALLOSE DEPOSITION | DEMETHYLATION | METHYLATION PATTERNS | PLANTS | Arabidopsis Proteins - genetics | Plant Immunity - genetics | Gene Expression Regulation, Plant - immunology | Plant Diseases - immunology | Arabidopsis - immunology | Gene Expression Regulation, Plant - genetics | DNA Methylation - genetics | Arabidopsis - metabolism | Arabidopsis - genetics | Arabidopsis Proteins - metabolism | Plant Diseases - genetics | Plant Immunity - immunology | DNA Methylation - physiology | Drug resistance in microorganisms | Transposons | DNA microarrays | Immune response | Methyltransferases | Analysis | Plant genetics | Genetic research | Methylation | Gene expression | Pathogens | Deoxyribonucleic acid--DNA | Botany | Original
Arabidopsis thaliana | systemic acquired resistance | defence priming | Hyaloperonospora arabidopsidis | E‐MTAB‐3963 | transgenerational acquired resistance | DNA methylation | basal resistance | E-MTAB-3963 | ACID | RNA-POLYMERASE V | TRANSPOSABLE ELEMENTS | HISTONE ACETYLTRANSFERASE | PLANT SCIENCES | GETTING READY | INDUCED RESISTANCE | CALLOSE DEPOSITION | DEMETHYLATION | METHYLATION PATTERNS | PLANTS | Arabidopsis Proteins - genetics | Plant Immunity - genetics | Gene Expression Regulation, Plant - immunology | Plant Diseases - immunology | Arabidopsis - immunology | Gene Expression Regulation, Plant - genetics | DNA Methylation - genetics | Arabidopsis - metabolism | Arabidopsis - genetics | Arabidopsis Proteins - metabolism | Plant Diseases - genetics | Plant Immunity - immunology | DNA Methylation - physiology | Drug resistance in microorganisms | Transposons | DNA microarrays | Immune response | Methyltransferases | Analysis | Plant genetics | Genetic research | Methylation | Gene expression | Pathogens | Deoxyribonucleic acid--DNA | Botany | Original
Journal Article